BIOY vs SCHD
GraniteShares YieldBOOST Biotech ETF vs Schwab US Dividend Equity ETF
Quick Verdict
SCHD has a lower expense ratio. SCHD offers more diversification with 104 holdings.
Side-by-Side Comparison
| Metric | BIOY | SCHD | Winner |
|---|---|---|---|
| Expense Ratio | 1.07% | 0.06% | |
| AUM | $846,320.22 | $108.7B | |
| Dividend Yield | 16.47% | 3.13% | |
| Holdings | 0 | 104 | |
| YTD Return | +1.35% | +27.67% | |
| 1Y Return | - | +31.26% | |
| 3Y Return (annualized) | - | +16.66% | |
| 5Y Return (annualized) | - | +10.18% | |
| Volatility (annualized) | - | 13.6% | |
| Max Drawdown | -6.6% | -33.4% | |
| Fund Family | GraniteShares | Charles Schwab Asset Management | |
| Category | Alternative | Equity | |
| Inception | May 6, 2026 | Oct 20, 2011 |
BIOY vs SCHD Performance
GraniteShares YieldBOOST Biotech ETF (BIOY) is a ETF from GraniteShares and Schwab US Dividend Equity ETF (SCHD) is a ETF from Charles Schwab Asset Management. Year to date, BIOY is up 1.35% versus a gain of 27.67% for SCHD.
Risk: Volatility and Drawdowns
The deepest peak-to-trough decline in our data was -6.6% for BIOY and -33.4% for SCHD. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
Fees and Cost Over Time
BIOY charges 1.07% per year while SCHD charges 0.06%. On a $10,000 position that is $107 vs $6 annually, a gap of $101 per year that compounds over a long holding period. On income, BIOY currently yields 16.47% against 3.13% for SCHD.
Frequently Asked Questions
Which is cheaper, BIOY or SCHD?
BIOY has an expense ratio of 1.07% while SCHD charges 0.06%. SCHD is the cheaper option. On a $10,000 investment, that is $101 per year of difference.
Which pays a higher dividend, BIOY or SCHD?
BIOY yields 16.47% while SCHD yields 3.13%, so BIOY currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.